22 results on '"de Jong, Florus C."'
Search Results
2. Sewage surveillance system using urological wastewater: Key to COVID-19 monitoring?
3. Precision Medicine in Bladder Cancer
4. Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin
5. Clinical Decision Making in Surveillance of Non-Muscle-Invasive Bladder Cancer: The Evolving Roles of Urinary Cytology and Molecular Markers
6. High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes
7. Reply to Chao Song’s Letter to the Editor re: Florus C. de Jong, Iris G. Iflé, Angelique C. van der Made, et al. A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy. Eur Urol Open Sci 2024;62:131–9
8. MP59-05 FREQUENCY OF FIBROBLAST GROWTH FACTOR RECEPTOR ALTERATIONS AND ASSOCIATION WITH BACILLUS CALMETTE-GUERIN OUTCOMES IN A REAL-WORLD GENOMIC ANALYSIS OF HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER (GARNER) STUDY
9. MP06-01 NON-MUSCLE INVASIVE BLADDER CANCER SUBTYPES WITH DIFFERENTIAL RESPONSE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT
10. MP06-18 A GENOMIC URINE ASSAY TO DETECT URINARY TRACT RECURRENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADIOTHERAPY
11. Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer
12. Non-muscle Invasive Bladder Cancer Molecular Subtypes Predict Differential Response to Intravesical Bacillus Calmette-Guérin
13. MP66-01 RNA-SEQUENCING OF BCG TREATED BLADDER CANCER PATIENTS IDENTIFIES PATIENTS WITH AGGRESSIVE AND IMMUNE SUPPRESSIVE TUMORS AT RISK OF BCG FAILURE
14. Abstract 614: Transcriptomic analysis of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG-failure
15. Abstract 615: Differential pathway analyses of BCG-treated T1HG bladder cancer using Philips OncoSignal: A pilot study
16. Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer
17. Improving Anti-PD-1/PD-L1 Therapy for Localized Bladder Cancer
18. T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis
19. Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy
20. Abstract B06: Pathologic T1 substaging improves the identification of high-risk non-muscle invasive bladder cancer patients at risk of BCG failure
21. Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines
22. Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.